Adamson, J, Lally, J, Gaughran, F, et al. (2017) Correlates of vitamin D in psychotic disorders: a comprehensive systematic review. Psychiatry Research, 249: 78–85.
Alavi, NM, Khademalhoseini, S, Vakili, Z, et al. (2018) Effect of vitamin D supplementation on depression in elderly patients: a randomized clinical trial. Clinical Nutrition, : doi 10.1016/j.clnu.2018.09.011 .
Albayrak, Y, Ünsal, C, Beyazyüz, M, et al. (2013) Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 45: 144–9.
Anglin, RE, Samaan, Z, Walter, SD, et al. (2013) Vitamin D deficiency and depression in adults: systematic review and meta-analysis. British Journal of Psychiatry, 202: 100–7.
Aspray, TJ, Bowring, C, Fraser, W, et al. (2014) National Osteoporosis Society vitamin D guideline summary. Age and Ageing, 43: 592–5.
Bergemann, N, Parzer, P, Mundt, C, et al. (2008) High bone turnover but normal bone mineral density in women suffering from schizophrenia. Psychological Medicine, 38: 1195–201.
Chan, R, Chan, D, Woo, J, et al. (2011) Association between serum 25-hydroxyvitamin D and psychological health in older Chinese men in a cohort study. Journal of Affective Disorders, 130: 251–9.
Chen, N, Wan, Z, Han, SF, et al. (2014) Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients, 6: 2206–16.
Chowdhury, R, Kunutsor, S, Vitezova, A, et al. (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ, 348: g1903.
Crews, M, Lally, J, Gardner-Sood, P, et al. (2013) Vitamin D deficiency in first episode psychosis: a case–control study. Schizophrenia Research, 150: 533–7.
Davies, G, Welham, J, Chant, D, et al. (2003) A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophrenia Bulletin, 29: 587–93.
Dawson-Hughes, B, Mithal, A, Bonjour, J-P, et al. (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporosis International, 21: 1151–4.
Dean, AJ, Bellgrove, MA, Hall, T, et al. (2011) Effects of vitamin D supplementation on cognitive and emotional functioning in young adults – a randomised controlled trial. PLoS One, 6: e25966.
Dumville, JC, Miles, JN, Porthouse, J, et al. (2006) Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. Journal of Nutrition, Health and Aging, 10: 151–3.
Ebeling, PR (2014) Vitamin D and bone health: epidemiologic studies. BoneKEy Reports, 3: 511.
Egerton, A, Brugger, S, Raffin, M, et al. (2012) Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology, 37: 2515–21.
Eyles, DW, Burne, TH, McGrath, JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology, 34: 47–64.
Eyles, DW, Trzaskowski, M, Vinkhuyzen, AAE, et al. (2018) The association between neonatal vitamin D status and risk of schizophrenia. Scientific Reports, 8: 17692.
Ford, L, Graham, V, Wall, A, et al. (2006) Vitamin D concentrations in an UK inner-city multicultural outpatient population. Annals of Clinical Biochemistry, 43: 468–73.
Garcion, E, Thanh, XD, Bled, F, et al. (1996) 1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain. Neuroscience Letters, 216: 183–6.
Garcion, E, Wion-Barbot, N, Montero-Menei, CN, et al. (2002) New clues about vitamin D functions in the nervous system. Trends in Endocrinology and Metabolism, 13: 100–5.
Gloth, FM III, Alam, W, Hollis, B (1999) Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. Journal of Nutrition, Health and Aging, 3: 5–7.
Gomez, L, Stubbs, B, Shirazi, A, et al. (2016) Lower bone mineral density at the hip and lumbar spine in people with psychosis versus controls: a comprehensive review and skeletal site-specific meta-analysis. Current Osteoporosis Reports, 14: 249–59.
Graham, KA, Keefe, RS, Lieberman, JA, et al. (2015) Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Intervention in Psychiatry, 9: 397–405.
Hallahan, B, Lyons, D, Doyle, P (2008) Bone mineral density and general health of long-term residential psychiatric inpatients. Irish Journal of Psychological Medicine, 25: 95–9.
Harms, LR, Eyles, DW, McGrath, JJ, et al. (2008) Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice. Behavioural Brain Research, 187: 343–50.
Hilger, J, Friedel, A, Herr, R, et al. (2014) A systematic review of vitamin D status in populations worldwide. British Journal of Nutrition, 111: 23–45.
Holick, MF (1995) Environmental factors that influence the cutaneous production of vitamin D. American Journal of Clinical Nutrition, 61: 638S–45S.
Holick, MF, Chen, TC, Lu, Z, et al. (2007) Vitamin D and skin physiology: a D-lightful story. Journal of Bone and Mineral Research, 22(suppl 2): V28–33.
Holick, M, Chen, T (2008) Vitamin D deficiency: a worldwide problem with health consequences. American Journal of Clinical Nutrition, 87: 1080S–6S.
Holick, MF, Binkley, NC, Bischoff-Ferrari, HA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 96: 1911–30.
Holick, MF (2013) Vitamin D: physiology, dietary sources, and requirements. In Encyclopedia of Human Nutrition (3rd edn) (eds Caballero, B, Allen, L, Prentice, A): 323–32. Academic Press.
Hypponen, E, Power, C (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. American Journal of Clinical Nutrition, 85: 860–8.
Jiang, X, O'Reilly, PF, Aschard, H, et al. (2018) Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nature Communications, 9: 260.
Jorde, R, Sneve, M, Figenschau, Y, et al. (2008) Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. Journal of Internal Medicine, 264: 599–609.
Jovanova, O, Aarts, N, Noordam, R, et al. (2017) Vitamin D serum levels are cross-sectionally but not prospectively associated with late-life depression. Acta Psychiatrica Scandinavica, 135: 185–94.
Khoraminya, N, Tehrani-Doost, M, Jazayeri, S, et al. (2013) Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Australian and New Zealand Journal of Psychiatry, 47: 271–5.
Kjærgaard, M, Waterloo, K, Wang, CE, et al. (2012) Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case–control study and randomised clinical trial. British Journal of Psychiatry, 201: 360–8.
Krivoy, A, Onn, R, Vilner, Y, et al. (2017) Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial. EBioMedicine, 26: 138–45.
Lally, J, Gardner-Sood, P, Firdosi, M, et al. (2016) Clinical correlates of vitamin D deficiency in established psychosis. BMC Psychiatry, 16: 1–9.
Lally, J, Ajnakina, O, Stubbs, B, et al. (2017) Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies. British Journal of Psychiatry, 211: 350–8.
Lally, J, Ajnakina, O, Singh, N, et al. (2018) Vitamin D and clinical symptoms in First Episode Psychosis (FEP): a prospective cohort study. Schizophrenia Research, : doi 10.1016/j.schres.2018.08.011 .
Li, G, Mbuagbaw, L, Samaan, Z, et al. (2014) Efficacy of vitamin D supplementation in depression in adults: a systematic review. Journal of Clinical Endocrinology and Metabolism, 99: 757–67.
Lips, P (2007) Relative value of 25(OH)D and 1,25(OH)2D measurements. Journal of Bone and Mineral Research, 22: 1668–71.
Manson, JE, Cook, NR, Lee, IM, et al. (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 380: 33–44.
Marsh, WK, Penny, JL, Rothschild, AJ (2017) Vitamin D supplementation in bipolar depression: a double blind placebo controlled trial. Journal of Psychiatric Research, 95: 48–53.
May, HT, Bair, TL, Lappe, DL, et al. (2010) Association of vitamin D levels with incident depression among a general cardiovascular population. American Heart Journal, 159: 1037–43.
McGrath, J (1999) Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophrenia Research, 40: 173–7.
McGrath, J, Saari, K, Hakko, H, et al. (2004) Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophrenia Research, 67: 237–45.
McGrath, JJ, Eyles, DW, Pedersen, CB, et al. (2010) Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Archives of General Psychiatry, 67: 889–94.
Milaneschi, Y, Shardell, M, Corsi, AM, et al. (2010) Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. Journal of Clinical Endocrinology and Metabolism, 95: 3225–33.
Mitra, S, Natarajan, R, Ziedonis, D, et al. (2017) Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 78: 1–11.
Mozaffari-Khosravi, H, Nabizade, L, Yassini-Ardakani, SM, et al. (2013) The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. Journal of Clinical Psychopharmacology, 33: 378–85.
Nerhus, M, Berg, AO, Kvitland, LR, et al. (2016) Low vitamin D is associated with negative and depressive symptoms in psychotic disorders. Schizophrenia Research, 178: 44–9.
Nowson, CA, McGrath, JJ, Ebeling, PR, et al. (2012) Vitamin D and health in adults in Australia and New Zealand: a position statement. Medical Journal of Australia, 196: 686–7.
Rey-Sanchez, P, Lavado-Garcia, JM, Canal-Macias, ML, et al. (2009) Ultrasound bone mass in schizophrenic patients on antipsychotic therapy. Human Psychopharmacology, 24: 49–54.
Ross, AC, Manson, JE, Abrams, SA, et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism, 96: 53–8.
Saha, S, Chant, DC, Welham, JL, et al. (2006) The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatrica Scandinavica, 114: 36–9.
Sepehrmanesh, Z, Kolahdooz, F, Abedi, F, et al. (2016) Vitamin D supplementation affects the Beck Depression Inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. Journal of Nutrition, 146: 243–8.
Stubbs, B, de Hert, M, Sepehry, AA, et al. (2014) A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia. Acta Psychiatrica Scandinavica, 130: 470–86.
Suetani, S, Saha, S, Eyles, DW, et al. (2017) Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: data from the Australian Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 9: 921–9.
Sullivan, EM, O'Donnell, P (2012) Inhibitory interneurons, oxidative stress, and schizophrenia. Schizophrenia Bulletin, 38: 373–6.
Toffanello, ED, Sergi, G, Veronese, N, et al. (2014) Serum 25-hydroxyvitamin d and the onset of late-life depressive mood in older men and women: the Pro.V.A. study. Journals of Gerontology. Series A, 69: 1554–61.
Vieth, R, Kimball, S, Hu, A, et al. (2004) Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutrition Journal, 3: 8.
Wang, TJ, Pencina, MJ, Booth, SL, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation, 117: 503–11.
Wang, Y, Liu, Y, Lian, Y, et al. (2016) Efficacy of high-dose supplementation with oral vitamin D3 on depressive symptoms in dialysis patients with vitamin D3 insufficiency: a prospective, randomized, double-blind study. Journal of Clinical Psychopharmacology, 36: 229–35.
Wortsman, J, Matsuoka, LY, Chen, TC, et al. (2000) Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition, 72: 690–3.
Wrzosek, M, Łukaszkiewicz, J, Wrzosek, M, et al. (2013) Vitamin D and the central nervous system. Pharmacological Reports, 65: 271–8.
Yalamanchili, V, Gallagher, JC (2012) Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms. Menopause, 19: 697–703.
Yuksel, RN, Altunsoy, N, Tikir, B, et al. (2014) Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Therapeutic Advances in Psychopharmacology, 4: 268–75.
Zanetidou, S, Belvederi Murri, M, Buffa, A, et al. (2011) Vitamin D supplements in geriatric major depression. International Journal of Geriatric Psychiatry, 26: 1209–10.